Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles
- PMID: 1586719
Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles
Abstract
The respiratory burst induced in human eosinophils by serum-treated zymosan (STZ) was found to be almost completely prevented by preincubation of the cells with WEB 2086, an antagonist of platelet-activating factor (PAF). When eosinophils were primed by the addition of 1 mumol/L PAF, subsequent addition of WEB 2086 had only a minor effect on the STZ-induced respiratory burst. These results suggest a role for PAF synthesis and PAF release in the activation of the respiratory burst by STZ. Indeed, supernatant of STZ-stimulated eosinophils was able to prime fresh eosinophils (as did PAF itself), and this effect was again inhibited by WEB 2086. This indicates that eosinophils synthesize and release PAF during STZ stimulation. Measurements of total PAF and PAF release showed that most of the PAF synthesized by eosinophils was released in the extracellular medium. This study shows that synthesis and release of PAF is important for respiratory burst activity induced in human eosinophils by STZ.
Similar articles
-
Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils.Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):95-101. Biochem J. 1999. PMID: 10229663 Free PMC article.
-
Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils.J Immunol. 1994 Sep 15;153(6):2729-35. J Immunol. 1994. PMID: 8077677
-
Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles.J Immunol. 1992 Dec 1;149(11):3672-7. J Immunol. 1992. PMID: 1431137
-
The effects of hetrazepine PAF antagonists in preclinical models of asthma.Agents Actions Suppl. 1991;34:229-45. Agents Actions Suppl. 1991. PMID: 1793067 Review.
-
Role for platelet-activating factor in asthma.Lipids. 1991 Dec;26(12):1277-9. doi: 10.1007/BF02536547. Lipids. 1991. PMID: 1819715 Review.
Cited by
-
Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.Br J Pharmacol. 2002 Mar;135(5):1213-8. doi: 10.1038/sj.bjp.0704570. Br J Pharmacol. 2002. PMID: 11877329 Free PMC article.
-
Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils.Drugs. 1993;46 Suppl 1:52-8. doi: 10.2165/00003495-199300461-00011. Drugs. 1993. PMID: 7506195
-
Pharmacological comparison of LTB(4)-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils.Br J Pharmacol. 2001 Oct;134(4):797-806. doi: 10.1038/sj.bjp.0704314. Br J Pharmacol. 2001. PMID: 11606320 Free PMC article.
-
Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils.Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):95-101. Biochem J. 1999. PMID: 10229663 Free PMC article.
-
Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1994 Sep;48(3):431-54. doi: 10.2165/00003495-199448030-00009. Drugs. 1994. PMID: 7527762 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources